TrueTicker

NIFTY 500 › Chemicals

Chemicals · NIFTY 500

PI Industries Ltd.

PIIND on NSE · 19 Nov 2026

NIFTY 500 F&O

1,630.00 ▲ +0.37 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Options Guidance & governance

Filings

35 filings of PIIND since November 2024.

transcript 9, board outcome 8, dividend 6, presentation 6, acquisition 3, results 2

FiledTypeSubject
12 Nov 2026transcript
Results
PIIND: PI Industries Limited has informed the Exchange about Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2026
AI summary

PI Industries filed the transcript of its Q2 and H1 FY27 earnings conference call held on November 5, 2026, covering results for the quarter and half year ended September 30, 2026.

Sanjay Agarwal (Group CFO) said Q2 FY27 consolidated revenue was Rs. 17,018 million, down 9% year-on-year, with gross margin at 49% and EBITDA margin at 14%.

Agarwal said AgChem exports declined 18% in the period, with volume down a lower single digit (about 3% to 4%, per Mayank Singhal in Q&A), and domestic Agri grew 19%; biologicals grew 45% domestically and global biologicals revenue grew more than 250%.

Singhal said the global crop protection cycle is at low points, with generic pricing pressure and a weak Indian monsoon, and that PI is planning a cautious Rabi season.

Agarwal said net working capital was reduced by 18 days, releasing Rs. 298 crores, operating cash flow was Rs. 9.1 billion, and net cash stood at Rs. 36 billion.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
04 Nov 2026presentation
Capex, Results
PI Industries Limited has informed the Exchange about Investor Presentation
AI summary

PI Industries filed the investor presentation for its earnings conference call on Q2 FY27 and H1 FY27 unaudited results (quarter and half year ended September 30, 2026), with the call scheduled for November 5, 2026 at 12:00 noon IST.

Q2FY27 consolidated revenue was INR 17,018 Mn (Q2FY26: INR 18,723 Mn), EBITDA INR 2,362 Mn (Q2FY26: INR 5,434 Mn) and net profit INR 1,222 Mn (Q2FY26: INR 4,093 Mn).

H1FY27 consolidated revenue was INR 34,041 Mn (H1FY26: INR 37,728 Mn), EBITDA INR 6,055 Mn and net profit INR 3,664 Mn (H1FY26: INR 8,093 Mn).

Management said Agchem exports declined about 18% in Q2 on lower demand, genericization and pricing pressure, while domestic revenue grew about 19% and Biologicals grew 45%+ domestically and +250% globally.

Management said net working capital days fell by 18 days to 121 days in September 2026, releasing INR 2,981 Mn of cash, and H1 FY27 capex was INR 5,674 Mn.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
04 Nov 2026board outcome
Results
PI Industries Limited has submitted to the Exchange, the Outcome of Board Meeting held on November 04, 2026 for approval of Unaudited Standalone and Consolidated Financial Results for the quarter and half year September 30, 2026.
AI summary

PI Industries Limited filed the outcome of its board meeting held November 4, 2026, which approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

Standalone revenue from operations for Q2 FY27 was Rs 15,335 million, down from Rs 17,526 million in the year-ago quarter; half-year revenue was Rs 31,324 million versus Rs 35,217 million.

Standalone net profit for the quarter was Rs 2,071 million against Rs 4,911 million a year earlier; half-year profit was Rs 5,486 million versus Rs 9,554 million.

Basic EPS for the quarter was Rs 13.66 against Rs 32.36 a year earlier (face value Rs 1 per share).

The board meeting ran from 2:00 p.m. to 7:00 p.m. IST; the filing contains no management commentary.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
19 Oct 2026acquisition
Acquisition
PI Industries Limited has informed the Exchange about Update on Incorporation of a Wholly Owned Subsidiary of the Company namely PI Foundation under section 8 of the Companies Act, 2013.
AI summary

PI Industries Limited filed a Regulation 30 update on incorporation of a wholly owned subsidiary, "PI Foundation".

PI Foundation was incorporated on October 19, 2026 in Udaipur, Rajasthan, as a not-for-profit company under Section 8 of the Companies Act, 2013, for CSR activities.

The initial share capital subscription was Rs. 1,00,000 in cash, and the Company along with its subsidiaries holds 100% of the entity.

The Certificate of Incorporation was issued by the Ministry of Corporate Affairs on October 19, 2026, following the Board approval of August 11, 2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
18 Aug 2026transcript
Guidance, Results
PI Industries Limited has informed the Exchange about Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter ended June 30, 2026
AI summary

PI Industries filed the transcript of its Q1 FY27 earnings conference call, held on August 12, 2026, to discuss results for the quarter ended June 30, 2026.

Sanjay Agarwal (Group CFO) said reported revenue for Q1 FY27 was Rs. 17,023 million, with gross margin of 57% and EBITDA of Rs. 3,693 million (22% margin).

Management said domestic agri volumes grew 12% and revenue grew 3%, and biologicals grew 50%, while export operating conditions remain challenging.

Management said it expects FY27 to be better than FY26, driven by a recovery in exports in the second half, and expects an effective tax rate of about 24% for FY27.

Management said net working capital fell by 19 days, releasing INR 300 crore of cash, and the company has net cash of INR 38 billion.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
11 Aug 2026presentation
Capex, Results
PI Industries Limited has informed the Exchange about Investor Presentation
AI summary

PI Industries filed the investor presentation for its earnings conference call on the unaudited standalone and consolidated results for the quarter ended June 30, 2026, scheduled for August 12, 2026 at 12:00 noon (IST).

Consolidated Q1FY27 revenue was INR 17,023 Mn (down 10% YoY from INR 19,005 Mn), EBITDA was INR 3,693 Mn (down 29%, margin 22% vs 27%), and net profit was INR 2,442 Mn (down 39%).

Management said agchem exports fell about 12% (volume down 8%) due to soft global agrochemical demand, while domestic volume rose about 12% (revenue up about 3%) with Biologicals growing 50%+ YoY.

Management cited pricing pressure, a delayed monsoon, a 25% YoY revenue decline in PIHS on order phasing, and higher input material prices from geopolitical issues as factors hitting gross margin.

Net cash balance was INR 37,939 Mn, and total capex for Q1FY27 was INR 2,685 Mn; net working capital days reduced by 19 days to 120 days in June 2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
11 Aug 2026acquisition
Capex, Results
PI Industries Limited has informed the Exchange about proposed incorporation of a company under Section 8 of the Companies Act, 2013.
AI summary

PI Industries filed the outcome of its board meeting held August 11, 2026, approving unaudited standalone and consolidated results for the quarter ended June 30, 2026.

Standalone revenue from operations for Q1 FY27 was Rs 15,989 Mn, against Rs 17,691 Mn in the quarter ended June 30, 2025; profit for the period was Rs 3,415 Mn (Rs 4,643 Mn a year earlier) and basic EPS was Rs 22.50 (Rs 30.61).

The board also approved incorporation of PI Foundation, a Section 8 company under the Companies Act, 2013, as a wholly owned subsidiary (direct or indirect) of the company, subject to Registrar of Companies approval.

The standalone results include an exceptional gain/(loss) line; the notes refer to a Rs 1,100 Mn provision on the equity investment in PIHS recognised in the quarter ended March 31, 2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
11 Aug 2026board outcome
Capex, Results
PI Industries Limited has submitted to the Exchange, the Unaudited Financial Results for the period ended June 30, 2026.
AI summary

PI Industries Limited filed the outcome of its board meeting held on August 11, 2026, approving unaudited standalone and consolidated results for the quarter ended June 30, 2026.

Standalone revenue from operations for Q1 FY27 was Rs 15,989 million, against Rs 17,691 million in the quarter ended June 30, 2025 and Rs 13,914 million in the quarter ended March 31, 2026.

Standalone profit for the period was Rs 3,415 million, and basic EPS was Rs 22.50 (not annualised), against Rs 4,643 million and Rs 30.61 a year earlier.

The board also approved incorporation of 'PI Foundation', a Section 8 company, as a wholly owned subsidiary (direct or indirect) of the company, subject to Registrar of Companies approval.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
23 Jun 2026acquisition
Acquisition
PI Industries Limited has informed the Exchange about exercise of conversion option for unlisted, unsecured Optionally Fully Convertible Debentures issued by PI Health Sciences Limited, wholly owned subsidiary, into Equity Shares
AI summary

PI Industries' board approved on June 23, 2026 the conversion of unlisted, unsecured Optionally Fully Convertible Debentures held by the company in its wholly owned subsidiary PI Health Sciences Limited (PIHS).

The OFCDs of face value Rs. 70 each, aggregating Rs. 70,000,000,000 (Rs. 7,000 million), will be converted into 72,46,37,687 fully paid-up equity shares of face value Rs. 70.00 each at a fair value of Rs. 73.80 per share, based on an independent registered valuer's report.

The transaction involves no cash consideration or share swap and does not change PIHS's ownership or control; PIHS remains a wholly owned subsidiary.

The filing describes the transaction as a related party transaction undertaken in the ordinary course of business at arm's length; PIHS's standalone turnover as at March 31, 2026 was Rs. 580.49 million.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
26 May 2026transcript
Capex, Guidance, Management change, Results
PI Industries Limited has informed the Exchange about Transcript of the Earnings Conference Call held on May 20, 2026
AI summary

PI Industries filed the transcript of its Q4 FY26 earnings conference call held on May 20, 2026, to discuss audited results for the quarter and year ended March 31, 2026.

Management reported FY26 consolidated revenue of Rs 67,137 million with EBITDA margin of 25% and cash balance of Rs 34,265 million; Q4 FY26 revenue was Rs 15,652 million.

Management said gross margin expanded to 58% for the quarter and year, and the full-year effective tax rate was 22%, expected to rise to about 24% in FY27 and thereafter.

Management said it expects positive growth in FY27, led by export recovery in the second half and new product launches, and said capacity utilisation for FY26 was around 80%.

Management said the Pharma business grew 40% for the full year, and that Rajnish Sarna stepped down from executive responsibilities, including investor relations, while remaining a Non-Executive Director.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
19 May 2026presentation
Capex, Dividend / buy-back, Results
PI Industries Limited has informed the Exchange about Investor Presentation
AI summary

PI Industries filed the investor presentation for its earnings conference call on the audited results for the quarter and year ended March 31, 2026, to be held on May 20, 2026 at 3:00 PM IST.

Q4 FY26 consolidated revenue was INR 15,652 Mn (down 12% YoY from INR 17,871 Mn), EBITDA INR 3,373 Mn (down 26%) and net profit INR 2,002 Mn (down 39%).

FY26 consolidated revenue was INR 67,137 Mn (down 16% YoY), EBITDA INR 17,053 Mn (down 22%) and net profit INR 13,208 Mn (down 20%); FY26 net profit includes exceptional income of INR 1,260 Mn from writeback of contingent consideration.

The Board approved a final dividend for FY25-26 of Rs 10 per share, making total FY25-26 dividend Rs 15 per share including interim dividend.

Management said Agchem exports fell about 19% YoY in FY26 on a high base, domestic revenue fell about 7%, and Pharma revenue grew 40%; FY26 capex was INR 11,508 Mn.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
19 May 2026dividend
Dividend / buy-back, Management change, Results
PI Industries Limited has informed the Exchange that Board of Directors at its meeting held on May 19, 2026, recommended Final Dividend of Rs. 10.00 per equity share.
AI summary

PI Industries Limited filed the outcome of its Board meeting held on May 19, 2026, approving audited standalone and consolidated results for the quarter and year ended March 31, 2026.

Standalone revenue from operations for the year ended March 31, 2026 was Rs 61,827 million, against Rs 75,712 million a year earlier; standalone profit for the year was Rs 12,935 million (Rs 18,456 million in the prior year).

The Board recommended a final dividend of Rs 10 per share (1000%) on Re 1 face value equity shares, subject to AGM approval; with the Rs 5 interim dividend, total dividend for FY2025-26 is Rs 15 per share.

The Board also approved re-appointment of K.G. Goyal & Co. as cost auditors for FY2026-27, and recorded Rajnish Sarna's resignation as Joint Managing Director (re-designated Non-Executive, Non-Independent Director), Arvind Singhal's decision not to seek re-appointment at the AGM, and the appointment of Dr. Atul Kumar Gupta as Whole-time Director for three years from May 19, 2026.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
19 May 2026board outcome
Dividend / buy-back, Management change, Results
PI Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
AI summary

PI Industries Limited filed the outcome of its board meeting held on May 19, 2026, approving audited standalone and consolidated results for the quarter and year ended March 31, 2026.

Full-year FY2025-26 standalone revenue from operations was Rs 61,827 million, against Rs 75,712 million in FY2024-25; standalone profit for the year was Rs 12,935 million, and basic EPS for the year was Rs 94.57.

The board recommended a final dividend of Rs 10 per share (on face value Re 1), making a total of Rs 15 per share for FY2025-26 including an interim dividend of Rs 5 per share; this is subject to shareholder approval at the AGM.

The board approved re-appointment of Cost Auditors K.G. Goyal & Co. for FY2026-27, Dr. Atul Kumar Gupta as Additional and Whole-time Director for three years from May 19, 2026, and Mr. Rajnish Sarna's resignation as Joint Managing Director, with his re-designation as Non-Executive, Non-Independent Director.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
20 Feb 2026transcript
Guidance, Results
PI Industries Limited has informed the Exchange about Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31, 2025
AI summary

PI Industries filed the transcript of its Q3 FY26 earnings conference call held on February 13, 2026, discussing unaudited results for the quarter and nine months ended December 31, 2025.

Management (CFO Sanjay Agarwal) reported Q3 FY26 revenue of INR 13,757 million, against a high base, and said the sector is nearing stabilization with sequential improvement expected from Q4.

Management reported gross margin of 59% for the quarter and 27% EBITDA margin for the nine months; the Q3 net profit included exceptional income of INR 1,260 million from write-back of contingent consideration in pharma, partly offset by INR 209 million of retirement benefit provisioning under the New Labour Code.

Management said trade working capital rose to 139 days of sales and the company had net cash of INR 35 billion; it expects domestic growth to return from FY27 and maintained its FY26 EBITDA margin outlook of 25% to 26%.

Management (Executive Vice Chairperson Mayank Singhal) said it would give FY27 guidance after the year-end budgeting exercise.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Feb 2026presentation
Capex, Dividend / buy-back, Results
PI Industries Limited has informed the Exchange about Presentation of Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31, 2025.
AI summary

PI Industries filed the investor presentation for its earnings conference call on February 13, 2026, covering unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025.

Q3FY26 consolidated revenue was INR 13,757 Mn (down 28% YoY from INR 19,008 Mn), EBITDA INR 3,027 Mn (down 41%) and net profit INR 3,113 Mn (down 16%), with Q3 net profit including an exceptional income of INR 1,260 Mn from writeback of contingent consideration.

9MFY26 revenue was INR 51,485 Mn (down 17%), EBITDA INR 13,680 Mn (down 21%) and net profit INR 11,206 Mn (down 16%); capex for 9MFY26 was INR 7,225 Mn.

Management attributed the Q3 decline mainly to customer delivery phasing in Agchem Exports, softer domestic demand, erratic monsoon and lower commodity realisations, and said EBITDA margin was preserved at about 27% for 9MFY26.

The Board approved an interim dividend for FY25-26 of Rs 5.00 per share.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Feb 2026dividend
Dividend / buy-back, Results
PI Industries Limited has informed the Exchange that Board of Directors at its meeting held on February 12, 2026, declared Interim Dividend of Rs. 5 per equity share.
AI summary

The Board of PI Industries Limited, at its meeting on February 12, 2026, approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

Standalone revenue from operations for the quarter ended December 31, 2025 was Rs 12,696 million, against Rs 17,798 million a year earlier; standalone profit for the period was Rs 2,816 million (Rs 4,238 million a year earlier).

Standalone profit after tax for the nine months ended December 31, 2025 was Rs 12,370 million, against Rs 14,807 million a year earlier.

The Board declared an interim dividend of Rs 5 per equity share (500% on face value of Re 1), payable on or before March 13, 2026, with February 23, 2026 fixed as the record date.

The company recognised a Rs 206 million exceptional item for incremental employee benefit liability arising from the New Labour Codes effective November 21, 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Feb 2026board outcome
Dividend / buy-back, Results
PI Industries Limited has submitted to the Exchange, the financial results for the quarter and nine months December 31, 2025.
AI summary

PI Industries' board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, with limited review reports from statutory auditors enclosed.

Standalone revenue from operations was Rs 12,696 million for the quarter ended December 31, 2025, versus Rs 17,798 million a year earlier; standalone profit for the period was Rs 2,816 million versus Rs 4,238 million.

Standalone profit for the nine months ended December 31, 2025 was Rs 12,370 million, versus Rs 14,807 million a year earlier.

The board declared an interim dividend of Rs 5 per equity share (face value Re 1), payable on or before March 13, 2026, with February 23, 2026 fixed as the record date.

The results include an exceptional charge of Rs 206 million for incremental employee benefit liability arising from the New Labour Codes effective November 21, 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
19 Nov 2025transcript
Guidance, Results
PI Industries Limited has informed the Exchange about Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2025
AI summary

PI Industries filed the transcript of its Q2 FY26 earnings conference call held on November 12, 2025, covering unaudited results for the quarter and half year ended September 30, 2025.

Management (CFO Sanjay Agarwal) reported Q2 FY26 revenue of Rs. 18,723 million, down 16% year-on-year from a high base and down 1% sequentially; H1 revenue declined 12%.

Management said the domestic business and biologicals were hit by erratic rains and abrupt regulatory changes, and AgChem Exports decline was mainly volume-led, which it expects to be transitory.

Management expects the effective tax rate to be in the range of 22%-23% for the next 2-3 years, and trade working capital at 113 days of sales, expected to improve as markets normalise.

Management (CEO Mayank Singhal) said it remains on track to commercialise 8 to 10 new molecules in FY26, with 5 commercialised in H1, and expects recovery in H2, mainly from Q4.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
11 Nov 2025board outcome
Results
PI Industries Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025.
AI summary

PI Industries Ltd filed its board meeting outcome, approving unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, with limited review reports from the statutory auditors.

Standalone revenue from operations for Q2 FY26 (quarter ended 30.09.2025) was Rs 17,526 million, against Rs 21,312 million in the year-ago quarter; half-year revenue was Rs 35,217 million versus Rs 41,432 million.

Standalone profit for the period was Rs 4,911 million for the quarter (Rs 5,585 million a year earlier) and Rs 9,554 million for the half year (Rs 10,569 million a year earlier).

Basic EPS for the quarter was Rs 32.36 (Rs 36.82 a year earlier); half-year basic EPS was Rs 62.97 (Rs 69.67 a year earlier).

The board meeting ran from 11:45 A.M. to 03:15 P.M. IST on November 11, 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
21 Aug 2025transcript
Capex, Guidance, Results
PI Industries Limited has informed the Exchange about Transcript
AI summary

PI Industries filed the transcript of its Q1 FY26 earnings conference call held on August 13, 2025, covering results for the quarter ended June 30, 2025.

Management reported Q1 FY26 consolidated revenue of Rs. 19,005 million, down 8% year-on-year and up 7% sequentially; gross margin was 57.4% and EBITDA margin 27.5%.

Management said the pharma revenue grew 186% year-on-year, the domestic business grew 6%, and the biological segment declined due to regulatory changes.

Management said it expects single-digit revenue growth for FY26 with a sustained EBITDA margin, reaffirmed the 50%-52% gross margin and 25%-27% EBITDA margin range, and plans investment of about Rs. 700 crore to Rs. 800 crore during the year.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Aug 2025board outcome
Results
PI Industries Limited has submitted to the Exchange, the Unaudited Standalone & Consolidated Financial Results for the quarter ended Jun 30, 2025.
AI summary

PI Industries Ltd filed the outcome of its board meeting held August 12, 2025, approving unaudited standalone and consolidated financial results for the quarter ended June 30, 2025.

Standalone revenue from operations for Q1 FY26 was Rs 17,691 million, against Rs 20,120 million in the year-ago quarter (June 30, 2024).

Standalone profit for the period was Rs 4,643 million, against Rs 4,984 million in the year-ago quarter; basic EPS was Rs 30.61, against Rs 32.85.

The board meeting ran from 2:00 PM to 6:30 PM (IST), and a limited review report by the statutory auditor is enclosed.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Aug 2025board outcome
Results
PI Industries Limited has submitted to the Exchange, the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended June 30, 2025.
AI summary

PI Industries Ltd filed the outcome of its board meeting held on August 12, 2025, approving unaudited standalone and consolidated financial results for the quarter ended June 30, 2025.

Standalone revenue from operations for Q1 FY26 was ₹17,691 million, against ₹20,120 million in the year-ago quarter (June 30, 2024).

Standalone profit for the period was ₹4,643 million, against ₹4,984 million in the year-ago quarter; basic EPS was ₹30.61 versus ₹32.85.

The board meeting ran from 2:00 P.M. to 6:30 P.M. (IST), and the limited review report from Price Waterhouse Chartered Accountants LLP was enclosed.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
26 May 2025transcript
Guidance, Results
PI Industries Limited has informed the Exchange about Transcript
AI summary

PI Industries filed the transcript of its Q4 and FY25 earnings conference call held on May 20, 2025, covering audited results for the quarter and year ended March 31, 2025.

Management (Group CFO Sanjay Agarwal) said Q4 FY25 consolidated revenue was Rs. 17,871 million, up 3% YoY, with consolidated EBITDA up 3% at a 25.6% margin.

For FY25, consolidated revenue was Rs. 79,778 million, up 4%, and consolidated profit was Rs. 16,602 million, down 1%, with ETR at 22.5% and expected at 22%-23% for the next 2-3 years.

Management (Mayank Singhal) said long-term EBITDA margin guidelines remain around 25% and it maintains its growth outlook, expecting sentiment to improve in the second half of the year.

Management said pharma EBITDA loss for FY25 was around Rs. 180-190 crore and aspirational biologicals revenue of about Rs. 250 crore could reach Rs. 1,000-1,200 crore in five years.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
19 May 2025dividend
Dividend / buy-back, Management change, Results
PI Industries Limited has informed the Exchange that Board of Directors at its meeting held on May 19, 2025, recommended Final Dividend of Rs. 10 per equity share.
AI summary

PI Industries filed the outcome of its Board meeting held on May 19, 2025, approving audited standalone and consolidated results for the quarter and financial year ended March 31, 2025.

The Board recommended a final dividend of Rs 10 per equity share (1000% on Re 1 face value) for FY 2024-25, subject to member approval at the AGM; with the interim dividend of Rs 6 per share, the total FY dividend is Rs 16 per share.

Record date for the final dividend is August 07, 2025; the 78th AGM is scheduled for August 14, 2025 via VC/OAVM.

The Board also approved appointment of Makarand M. Joshi & Co. as Secretarial Auditor for five years from FY 2025-26, re-appointment of K.G. Goyal & Co. as Cost Auditors for FY 2025-26, and several director appointments and re-appointments subject to member approval.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
19 May 2025board outcome
Dividend / buy-back, Legal, Management change, Results
PI Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
AI summary

PI Industries Board approved audited standalone and consolidated results for the quarter and financial year ended March 31, 2025, with auditor reports enclosed.

Board recommended a final dividend of Rs.10 per equity share (1000% on face value of Re.1) for FY 2024-25, subject to AGM approval; total FY dividend with interim Rs.6 is Rs.16 per share.

Record date for final dividend fixed as August 07, 2025; 78th AGM scheduled for August 14, 2025 via VC/OAVM.

Board approved appointment of M/s Makarand M. Joshi & Co. as Secretarial Auditor for five years from FY 2025-26, and re-appointment of K.G. Goyal & Co. as Cost Auditors for FY 2025-26, subject to member approval.

Board approved re-appointment of Mayank Singhal as Vice Chairperson & MD (Oct 1, 2025 to Sep 30, 2030), re-appointment of Rajnish Sarna as Joint MD (Nov 7, 2025 to Nov 6, 2028), re-appointment of Lisa J. Brown as Independent Director (Sep 25, 2025 to Sep 24, 2030), appointment of T.S. Balganesh as Non-Executive Non-Independent Director from Sep 5, 2025, and appointment of V. K. Viswanathan as Additional Independent Director from May 19, 2025 for five years.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
19 May 2025dividend
Dividend / buy-back, Legal, Management change, Results
PI Industries Limited has informed the Exchange that Board of Directors at its meeting held on May 19, 2025, recommended Final Dividend of 10 per equity share.
AI summary

PI Industries filed the outcome of its Board meeting held May 19, 2025, approving audited standalone and consolidated results for the quarter and year ended March 31, 2025.

The Board recommended a final dividend of Rs.10/- per equity share (face value Re.1/-) for FY 2024-25, subject to member approval at the AGM; with the interim dividend of Rs.6/- paid during the year, the total for the year is Rs.16/- per share.

Record date for the final dividend is Thursday, August 07, 2025; the 78th AGM is set for Thursday, August 14, 2025, via VC/OAVM.

The Board also approved secretarial auditor and cost auditor appointments and several director re-appointments and appointments, subject to member approval.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
24 Apr 2025credit rating
Rating
PI Industries Limited has informed the Exchange about Credit Rating
AI summary

PI Industries Ltd filed a Regulation 30 disclosure dated April 24, 2025, on a credit rating review by CRISIL Ratings.

CRISIL reaffirmed the company's long-term rating at CRISIL AA+/Stable.

CRISIL reaffirmed the company's short-term rating at CRISIL A1+.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
07 Mar 2025presentation
Guidance, Results
PI Industries Limited has informed the Exchange about Investor Presentation
AI summary

PI Industries filed the presentation for its investor and analyst meet held on March 7, 2025, under Regulations 30 and 46 of the SEBI Listing Obligations and Disclosure Requirements, Regulations 2015.

The presentation is titled "Transforming into LifeSciences Powerhouse" and is also posted on the company's website.

Management said the company has 60+ molecules in active pipeline, with over 50% in advanced stages of development, and 15+ molecules commercialised over the last few years.

Management said non-Agchem share of new enquiries rose from about 15% (FY20) to about 50% (FY25).

Management cited a revenue CAGR of 20% and EBITDA CAGR of 33% over the last 2 years, with ROCE above 30%.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
14 Feb 2025transcript
Capex, Guidance, Results
PI Industries Limited has informed the Exchange about Transcript
AI summary

PI Industries filed the transcript of its Q3 and 9M FY2025 earnings conference call, held February 7, 2025, on unaudited results for the quarter and nine months ended December 31, 2024.

Q3 FY25 consolidated revenue was Rs. 19,008 million, up 0.2% year-on-year; EBITDA was flat; the ETR rose from 14.7% to 22.5%. Domestic revenue rose 5% to Rs. 2,806 million and pharma revenue was Rs. 637 million.

For 9M FY25, revenue was Rs. 61,907 million (up 4%), EBITDA excluding pharma rose 17% to Rs. 18,760 million, and profit rose 1% to Rs. 13,297 million. Management expects FY25 ETR of 22% to 23%.

Management said pharma and biologicals are early-stage businesses, expects pharma growth of 20% to 25% once the CRDMO model stabilises in about a year, and said the diamide insecticide (PIOXANILIPROLE) is in Phase 3 trials.

Management said the agrochemical industry is in a transitional downswing, while the domestic generic segment faces pricing pressure and elevated inventory.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
06 Feb 2025presentation
Capex, Dividend / buy-back, Results
PI Industries Limited has informed the Exchange about Investor Presentation
AI summary

PI Industries filed a press release and investor presentation on its Q3 FY25 and nine-month FY25 results (quarter and nine months ended December 31, 2024).

Q3FY25 consolidated revenue was Rs. 19,008 million (up 0.2% YoY), EBITDA Rs. 5,122 million (down 8%), and net profit Rs. 3,727 million (down 17%); management attributed the profit fall to a higher effective tax rate of 22.5% versus 14.7%.

9MFY25 consolidated revenue was Rs. 61,907 million (up 4%), EBITDA Rs. 17,264 million (up 9%), and net profit Rs. 13,297 million (up 1%).

Management said the Board approved an interim dividend for FY24-25 of Rs. 6.00 per share.

Management said total capex for 9MFY25 was Rs. 6,485 million and trade working capital improved to 68 days from 80 days.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
06 Feb 2025results
Acquisition, Dividend / buy-back, Results
In compliance of Regulation 10(1A) of SEBI (Listing Obligations & Disclosure Requirements)Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185dated December 31, 2024 and BSE Circular No. 20250102-4 and NSE Circ
AI summary

PI Industries filed its integrated filing (financials) for the quarter and nine months ended December 31, 2024, with unaudited standalone results reviewed by Price Waterhouse Chartered Accountants LLP.

Standalone revenue from operations for the quarter ended December 31, 2024 was Rs 17,798 Mn, and for the nine months was Rs 59,230 Mn, with profit for the period of Rs 3,874 Mn (quarter) and Rs 14,262 Mn (nine months), as printed in the statement.

Basic EPS for the quarter was Rs 27.93 and for the nine months Rs 97.60, against Rs 32.04 and Rs 88.73 respectively for the corresponding periods of the prior year.

The Board approved an interim dividend of Rs 6.00 per equity share of face value Rs 1.00 for FY 2024-25.

The Company invested Rs 3,949 Mn in its wholly owned subsidiary PI Industries Management Consultancies L.L.C., Dubai, in the quarter ended September 30, 2024, and a further Rs 316 Mn in the current quarter.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
06 Feb 2025dividend
Dividend / buy-back, Results
PI Industries Limited has informed the Exchange that Board of Directors at its meeting held on February 06, 2025, declared Interim Dividend of Rs. 6 per equity share.
AI summary

PI Industries' board, meeting on February 06, 2025, approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024.

Board declared an interim dividend of Rs. 6.00 per equity share (600% on Re. 1 face value) for FY 2024-25, payable on or before March 06, 2025.

Record date for the interim dividend is February 14, 2025.

Standalone revenue from operations for the quarter ended December 31, 2024 was Rs. 17,798 million, and standalone profit for the period was Rs. 3,874 million (EPS Rs. 27.93).

Standalone revenue from operations for the nine months ended December 31, 2024 was Rs. 59,230 million, and standalone profit for the period was Rs. 14,262 million (EPS Rs. 97.60).

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
06 Feb 2025dividend
Dividend / buy-back, Results
PI Industries Limited has informed the Exchange that Board of Directors at its meeting held on February 06, 2025, declared Interim Dividend of 6 per equity share.
AI summary

PI Industries' board on February 06, 2025 approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, with a limited review report with unmodified opinion.

Board declared an interim dividend of Rs. 6.00 per equity share (600% on face value of Re. 1.00) for FY 2024-25, payable on or before March 06, 2025.

Record date for the interim dividend is February 14, 2025.

Standalone revenue from operations for the quarter ended December 31, 2024 was Rs. 17,798 million, against Rs. 21,312 million in the quarter ended September 30, 2024; standalone profit for the period was Rs. 3,874 million for the quarter.

Standalone revenue from operations for the nine months ended December 31, 2024 was Rs. 59,230 million, and profit for the period was Rs. 14,262 million.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
06 Feb 2025results
Dividend / buy-back, Results
PI Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
AI summary

PI Industries filed the outcome of its February 6, 2025 board meeting, approving unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2024.

Standalone revenue from operations for the quarter ended December 31, 2024 was Rs 17,798 million, against Rs 21,312 million in the quarter ended September 30, 2024 and Rs 17,212 million a year earlier; quarterly standalone profit for the period was Rs 3,874 million.

Standalone revenue from operations for the nine months ended December 31, 2024 was Rs 59,230 million, against Rs 55,191 million in the corresponding period of the previous year; nine-month profit was Rs 14,262 million.

The board declared an interim dividend of Rs 6.00 per equity share (600% on face value of Re 1), with a record date of February 14, 2025 and payment on or before March 6, 2025.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
20 Nov 2024transcript
Guidance, Results
PI Industries Limited has informed the Exchange about Transcript
AI summary

PI Industries filed the transcript of its Q2 and H1 FY25 earnings conference call held on November 14, 2024, covering results for the quarter and half year ended September 30, 2024.

Management (Sanjay Agarwal) reported Q2 consolidated revenue of Rs. 22,210 million, up 5% year-on-year, and profit after tax of Rs. 5,082 million, up 6%; H1 revenue was Rs. 42,899 million, up 7%, and H1 profit after tax was Rs. 9,571 million, up 11%.

Management (Mayank Singhal) re-aligned FY25 revenue growth outlook to high single digit for now, versus double digits earlier; Rajnish Sarna later said the company should aim for higher single-digit or near double-digit growth in FY25.

Management (Rajnish Sarna) said H1 pharma revenues were hit by innovator-level inventory and a customer filing Chapter 11, and that gross margins of 26-27% are considered sustainable for the core business.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy

The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in